Analyst Blum holds a conference call with CEO Gibson and CFO Secora to discuss the recently announced NVIDIA deal and the inclusion of Recursion’s platform on NVIDIA’s BioNeMo on July 20 at 2:15 pm hosted by Needham.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVDA:
- Analyst Sees Nvidia Revitalizing AI Stocks during Earnings Season
- AMD Stock Rally Is Not Yet Over; Analysts See Significant Upside
- Recursion Pharmaceuticals participates in a conference call with Needham
- Amid a Paradigm Shift, is Intel Stock (NASDAQ:INTC) Worth Buying?
- Tesla says in talks with major OEM to license FSD